Presidential Document2021-20737
Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2022
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
September 22, 2021
Signed
September 15, 2021
Issuing agencies
Executive Office of the President
Full Text
<html>
<head>
<title>Federal Register, Volume 86 Issue 181 (Wednesday, September 22, 2021)</title>
</head>
<body><pre>
[Federal Register Volume 86, Number 181 (Wednesday, September 22, 2021)]
[Presidential Documents]
[Pages 52819-52820]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2021-20737]
[[Page 52817]]
Vol. 86
Wednesday,
No. 181
September 22, 2021
Part IV
The President
-----------------------------------------------------------------------
Presidential Determination No. 2022-13 of September 15, 2021--
Presidential Determination on Major Drug Transit or Major Illicit Drug
Producing Countries for Fiscal Year 2022
Presidential Documents
Federal Register / Vol. 86 , No. 181 / Wednesday, September 22, 2021
/ Presidential Documents
___________________________________________________________________
Title 3--
The President
[[Page 52819]]
Presidential Determination No. 2021-13 of September 15,
2021
Presidential Determination on Major Drug Transit
or Major Illicit Drug Producing Countries for Fiscal
Year 2022
Memorandum for the Secretary of State
By the authority vested in me as President by the
Constitution and the laws of the United States,
including section 706(1) of the Foreign Relations
Authorization Act, Fiscal Year 2003 (Public Law 107-
228) (FRAA), I hereby identify the following countries
as major drug transit or major illicit drug producing
countries: Afghanistan, The Bahamas, Belize, Bolivia,
Burma, Colombia, Costa Rica, the Dominican Republic,
Ecuador, El Salvador, Guatemala, Haiti, Honduras,
India, Jamaica, Laos, Mexico, Nicaragua, Pakistan,
Panama, Peru, and Venezuela.
A country's presence on the foregoing list is neither a
reflection of its government's counterdrug efforts nor
level of cooperation with the United States. Consistent
with the statutory definition of a major drug transit
or major illicit drug producing country set forth in
section 481(e)(2) and (5) of the Foreign Assistance Act
of 1961, as amended (Public Law 87-195) (FAA), the
reason countries are placed on the list is the
combination of geographic, commercial, and economic
factors that allow drugs to be transited or produced,
even if a government has engaged in robust and diligent
narcotics control and law enforcement measures.
Pursuant to section 706(2)(A) of the FRAA, I hereby
designate Bolivia and Venezuela as having failed
demonstrably to make substantial efforts during the
previous 12 months to both adhere to their obligations
under international counternarcotics agreements and to
take the measures required by section 489(a)(1) of the
FAA. Included with this determination are
justifications for the designations of Bolivia and
Venezuela, as required by section 706(2)(B) of the
FRAA. I have also determined, in accordance with
provisions of section 706(3)(A) of the FRAA, that
United States programs that support Bolivia and
Venezuela are vital to the national interests of the
United States.
The ongoing drug addiction and overdose epidemic in the
United States is one of the foremost public health
priorities of my Administration, and addressing this
epidemic will require both new domestic investments and
greater cooperation with foreign partners to target
illicit drug suppliers and the criminal organizations
that profit from them. While creating our first-year
drug policy priorities, my Administration outlined a
strategy that includes expanding access to prevention,
treatment, evidence-based harm reduction, and recovery
support services in order to curb the drug addiction
and overdose epidemic. The American Rescue Plan Act of
2021 is an investment in these priorities, committing
nearly $4 billion to support behavioral health and
substance use disorder programs.
My Administration's Fiscal Year 2022 Budget request
itemizes $10.7 billion to support research, prevention,
treatment, evidence-based harm reduction, and recovery
support services, with targeted investments to meet the
needs of populations at greatest risk for overdose and
substance use disorder. The Budget request also
includes significant investments to reduce the supply
of illicit drugs originating from beyond our borders.
The United States is committed to working together with
the countries of the Western Hemisphere as neighbors
and partners to meet our shared challenges of drug
trafficking and use. My Administration will seek to
expand
[[Page 52820]]
cooperation with key partners, such as Mexico and
Colombia, to shape a collective and comprehensive
response and expand efforts to address the production
and trafficking of dangerous synthetic drugs that are
responsible for many of our overdose deaths,
particularly fentanyl, fentanyl analogues, and
methamphetamine. In Mexico, we must continue to work
together to intensify efforts to dismantle
transnational criminal organizations and their
networks, increase prosecutions of criminal leaders and
facilitators, and strengthen efforts to seize illicit
assets. In Bolivia, I encourage the government to take
additional steps to safeguard the country's licit coca
markets from criminal exploitation and reduce illicit
coca cultivation that continues to exceed legal limits
under Bolivia's domestic laws for medicinal and
traditional use. In addition, the United States will
look to expand cooperation with China, India, and other
chemical source countries in order to disrupt the
global flow of synthetic drugs and their precursor
chemicals.
You are authorized and directed to submit this
designation, with the Bolivia and Venezuela memoranda
of justification, under section 706 of the FRAA, to the
Congress, and to publish this determination in the
Federal Register.
<GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT>
(Presidential Sig.)
THE WHITE HOUSE,
Washington, September 15, 2021
[FR Doc. 2021-20737
Filed 9-21-21; 11:15 am]
Billing code 4710-10-P
</pre></body>
</html>Indexed from Federal Register on September 22, 2021.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.